| Gordon D, Schroeder M
Oral Transmucosal Fentanyl Citrate-OTFC (ACTIQ()) #103. [Journal Article]
J Palliat Med 2008 May; 11(4):633-4.
Full Citation |
| O'Connor AB
Is actiq use in noncancer-related pain really "a recipe for success"? [Journal Article]
Pain Med 2008 Mar; 9(2):258-60.
Full Citation |
| Laverty D
Treating cancer-related breakthrough pain: the oral transmucosal route. [Journal Article]
Int J Palliat Nurs 2007 Jul; 13(7):326-31.
Abstract | Full Citation | Find Related Articles |
| Laverty D
Actiq: an effective oral treatment for cancer-related breakthrough pain. [Journal Article]
Br J Community Nurs 2007 Jul; 12(7):311-6.
Abstract | Full Citation | Find Related Articles |
| Mystakidou K, Tsilika E, Tsiatas M, et al.
Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology. [Journal Article]
Int J Nanomedicine 2007; 2(1):49-54.
Abstract | Full Citation | Find Related Articles |
| Taylor DR, Webster LR, Chun SY, et al.
Impact of Breakthrough Pain on Quality of Life in Patients with Chronic, Noncancer Pain: Patient Perceptions and Effect of Treatment with Oral Transmucosal Fentanyl Citrate (OTFC, ACTIQ). [Journal Article]
Pain Med 2007 May-Jun; 8(3):281-8.
Abstract | Full Citation | Find Related Articles |
| Mystakidou K, Katsouda E, Parpa E, et al.
Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. [Journal Article]
J Opioid Manag 2005 Mar-Apr; 1(1):36-40.
Abstract | Full Citation |
| Passik SD, Kirsh KL
Weighing in on the Off-Label Use of Actiqtrade mark for Noncancer-Related Pain: A Recipe for Success or a Recipe for Disaster? [Journal Article]
Pain Med 2007 Mar-Apr; 8(2):130-3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Mystakidou K, Katsouda E, Parpa E, et al.
Oral transmucosal fentanyl citrate: overview of pharmacological and clinical characteristics. [Journal Article]
Drug Deliv 2006 Jul-Aug; 13(4):269-76.
Abstract | Full Citation | Find Related Articles |
| Mystakidou K, Katsouda E, Parpa E, et al.
Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. [Journal Article, Review]
Am J Hosp Palliat Care 2005 May-Jun; 22(3):228-32.
Abstract | Full Citation | Find Related Articles |
  |
